[1] SIU L K, YEH K M, LIN J C, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome[J]. Lancet Infect Dis, 2012, 12(11): 881-887. DOI:10.1016/S1473-3099(12)70205-0. [2] GU D X, DONG N, ZHENG Z W, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study[J]. Lancet Infect Dis, 2018, 18(1): 37-46. DOI:10.1016/S1473-3099(17)30489-9. [3] TURTON J F, ENGLENDER H, GABRIEL S N, et al. Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents[J]. J Med Microbiol, 2007, 56(5): 593-597. DOI:10.1099/jmm.0.46964-0. [4] VILA A, CASSATA A, PAGELLA H, et al. Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis[J]. Open Microbiol J, 2011, 5: 107-113. DOI:10.2174/1874285801105010107. [5] FUNG C P, LIN Y T, LIN J C, et al. Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess[J]. Emerg Infect Dis, 2012, 18(8): 1322-1325. DOI:10.3201/eid1808.111053. [6] CHEN N, WANG L L, XUE J, et al. Different metabolic profiles of K1 serotype and non-serotype K1 and K2 Klebsiella pneumoniae isolates in oral infection mice model[J]. Microb Pathog, 2014, 75: 41-48. DOI:10.1016/j.micpath.2014.08.006. [7] CHEN N, LING Z X, JIN T T, et al. Altered profiles of gut microbiota in Klebsiella pneumoniae -induced pyogenic liver abscess[J]. Curr Microbiol, 2018, 75(7): 952-959. DOI:10.1007/s00284-018-1471-7. [8] ANTUSHEVICH H. Fecal microbiota transplantation in disease therapy[J]. Clin Chimica Acta, 2020, 503: 90-98. DOI:10.1016/j.cca.2019.12.010. [9] BORODY T J, ESLICK G D, CLANCY R L. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer[J]. Curr Opin Pharmacol, 2019, 49: 43-51. DOI:10.1016/j.coph.2019.04.017. [10] KUETHE J W, ARMOCIDA S M, MIDURA E F, et al. Fecal microbiota transplant restores mucosal integrity in a murine model of burn injury[J]. Shock, 2016, 45(6): 647-652. DOI:10.1097/shk.0000000000000551. [11] CHEN N, JIN T T, LIU W N, et al. Gastric microbiota alteration in Klebsiella pneumoniae -caused liver abscesses mice[J]. Pol J Microbiol, 2019, 68(2): 247-254. DOI:10.33073/pjm-2019-026. [12] TAVOUKJIAN V. Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis[J]. J Hosp Infect, 2019, 102(2): 174-188. DOI:10.1016/j.jhin.2019.03.010. [13] GROSEN A K, POVLSEN J V, LEMMING L E, et al. Faecal microbiota transplantation eradicated extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from a renal transplant recipient with recurrent urinary tract infections[J]. Case Rep Nephrol Dial, 2019, 9(2): 102-107. DOI:10.1159/000502336. [14] WEINGARDEN A, GONZÁLEZ A, VÁZQUEZ-BAEZA Y, et al. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection[J]. Microbiome, 2015, 3: 10. DOI:10.1186/s40168-015-0070-0. [15] KONG C, GAO R Y, YAN X B, et al. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet[J]. Nutrition, 2019, 60: 175-184. DOI:10.1016/j.nut.2018.10.002. [16] KOH A, DE VADDER F, KOVATCHEVA-DATCHARY P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites[J]. Cell, 2016, 165(6):1332-1345. DOI: 10.1016/j.cell.2016.05.041. [17] AN L, WURI J, ZHENG Z, et al. Microbiota modulate doxorubicin induced cardiotoxicity[J]. Eur J Pharm Sci, 2021, 166:105977. DOI: 10.1016/j.ejps.2021.105977. [18] DEVLIN A S, FISCHBACH M A. A biosynthetic pathway for a prominent class of microbiota-derived bile acids[J]. Nat Chem Biol, 2015, 11(9):685-690. DOI: 10.1038/nchembio.1864. [19] SEEKATZ A M, THERIO C M, RAO K, et al. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection[J]. Anaerobe, 2018, 53:64-73. DOI: 10.1016/j.anaerobe.2018.04.001. [20] WU M, LI P, LI J, et al. The differences between luminal microbiota and mucosal microbiota in mice[J]. J Microbiol Biotechnol, 2020, 30(2): 287-295. DOI:10.4014/jmb.1908.08037. [21] XIAO S, LIU C, CHEN M, et al. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites[J]. Appl Microbiol Biotechnol, 2020, 104(1): 303-317. DOI:10.1007/s00253-019-10174-w. [22] DICKS L M T, DREYER L, SMITH C, et al. A review: the fate of bacteriocins in the human gastro-intestinal tract: do they cross the gut-blood barrier[J].Front Microbiol, 2018, 9:2297. DOI: 10.3389/fmicb.2018.02297. [23] LI X, SONG L, ZHU S, et al. Two strains of Lactobacilli effectively decrease the colonization of VRE in a mouse model[J]. Front Cell Infect Microbiol, 2019, 9:6. DOI: 10.3389/fcimb.2019.00006. [24] MCGUCKIN M A, LINDÉN S K, SUTTON P, et al. Mucin dynamics and enteric pathogens[J]. Nat Rev Microbiol, 2011, 9(4): 265-278. DOI:10.1038/nrmicro2538. [25] VAN KLINKEN B J, VAN DER WAL J W, EINERHAND A W, et al. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis[J]. Gut, 1999, 44(3): 387-393. DOI:10.1136/gut.44.3.387. [26] GOO N, BAE H J, PARK K, et al. The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice[J]. Life Sci, 2020, 262:118497. DOI: 10.1016/j.lfs.2020.118497. [27] AMBORT D, JOHANSSON M E, GUSTAFSSON J K, et al. Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin[J]. Proc Natl Acad Sci USA, 2012, 109(15):5645-5650. DOI: 10.1073/pnas.1120269109. [28] ZHOU J, ZHOU Z, JI P, et al. Effect of fecal microbiota transplantation on experimental colitis in mice[J]. Exp Ther Med, 2019, 17(4): 2581-2586. DOI:10.3892/etm.2019.7263. [29] WANG W W, ZHANG Y, HUANG X B, et al. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction[J]. World J Gastroenterol, 2017, 23(38): 6983-6994. DOI:10.3748/wjg.v23.i38.6983. ( |